Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ginny L. Emerson is active.

Publication


Featured researches published by Ginny L. Emerson.


Emerging Infectious Diseases | 2007

Brazilian vaccinia viruses and their origins.

Giliane de Souza Trindade; Ginny L. Emerson; Darin S. Carroll; Erna Geessien Kroon; Inger K. Damon

Genetic diversity enables this virus to persist in Brazil and other parts of the world.


PLOS ONE | 2009

The Phylogenetics and Ecology of the Orthopoxviruses Endemic to North America

Ginny L. Emerson; Yu Li; Michael Frace; Melissa Olsen-Rasmussen; Marina L. Khristova; Dhwani Govil; Scott Sammons; Russell L. Regnery; Kevin L. Karem; Inger K. Damon; Darin S. Carroll

The data presented herein support the North American orthopoxviruses (NA OPXV) in a sister relationship to all other currently described Orthopoxvirus (OPXV) species. This phylogenetic analysis reaffirms the identification of the NA OPXV as close relatives of “Old World” (Eurasian and African) OPXV and presents high support for deeper nodes within the Chordopoxvirinae family. The natural reservoir host(s) for many of the described OPXV species remains unknown although a clear virus-host association exists between the genus OPXV and several mammalian taxa. The hypothesized host associations and the deep divergence of the OPXV/NA OPXV clades depicted in this study may reflect the divergence patterns of the mammalian faunas of the Old and New World and reflect a more ancient presence of OPXV on what are now the American continents. Genes from the central region of the poxvirus genome are generally more conserved than genes from either end of the linear genome due to functional constraints imposed on viral replication abilities. The relatively slower evolution of these genes may more accurately reflect the deeper history among the poxvirus group, allowing for robust placement of the NA OPXV within Chordopoxvirinae. Sequence data for nine genes were compiled from three NA OPXV strains plus an additional 50 genomes collected from Genbank. The current, gene sequence based phylogenetic analysis reaffirms the identification of the NA OPXV as the nearest relatives of “Old World” OPXV and presents high support for deeper nodes within the Chordopoxvirinae family. Additionally, the substantial genetic distances that separate the currently described NA OPXV species indicate that it is likely that many more undescribed OPXV/NA OPXV species may be circulating among wild animals in North America.


Journal of Virological Methods | 2008

Real-time PCR assay to identify variants of Vaccinia virus: Implications for the diagnosis of bovine vaccinia in Brazil

Giliane de Souza Trindade; Yu Li; Victoria A. Olson; Ginny L. Emerson; Russell L. Regnery; Flávio Guimarães da Fonseca; Erna Geessien Kroon; Inger K. Damon

Naturally occurring infections of Vaccinia virus (VACV) have been recognized in Brazil during the past 10 years. Human Brazilian Vaccinia virus (BVV) infections typically occur as a zoonosis transferred from affected dairy cows to their handlers. Outbreaks have caused notable economic losses to the rural community in the region. The origins of BVV are unclear but previous analyses have shown that at least two distinct clades of BVV exist. The aim of this study was to develop a rapid and inexpensive process for identification and differentiation of BVV that should facilitate epidemiological and ecological investigations including the improved diagnosis of Brazilian Orthopoxvirus infections. A SYBR green quantitative real-time polymerase chain reaction (PCR) targeting the hemagglutinin gene was developed to identify different populations of BVV, VACV vaccine strains used in Brazil during the smallpox eradication campaign (Vaccinia Lister (VACV-LIS) and New York City Board of Health (VACV-NYCBH)), and currently available vaccines (VACV-NYCBH DRYVAX and VACV-NYCBH Acambis 2000). Three primer combinations (one to amplify many orthopoxviruses including all vaccinia viruses described so far; one to differentiate BVV from vaccine strains (VACV-LIS, VACV-NYCBH DRYVAX and VACV-NYCBH Acambis 2000); and one to differentiate BVV clades) were designed to work at the same annealing temperature and reaction conditions. In addition, these methods were able to detect orthopoxvirus viral DNA in lesion biopsy material without the need for DNA extraction.


Clinical Infectious Diseases | 2015

Risk Factors for Fatal Outcome From Rocky Mountain Spotted Fever in a Highly Endemic Area—Arizona, 2002–2011

Joanna J. Regan; Marc S. Traeger; Dwight Humpherys; Dianna L. Mahoney; Michelle Martinez; Ginny L. Emerson; Danielle M. Tack; Aimee Geissler; Seema Yasmin; Regina Lawson; Velda Williams; Charlene Hamilton; Craig Levy; Ken Komatsu; David A. Yost; Jennifer H. McQuiston

BACKGROUND Rocky Mountain spotted fever (RMSF) is a disease that now causes significant morbidity and mortality on several American Indian reservations in Arizona. Although the disease is treatable, reported RMSF case fatality rates from this region are high (7%) compared to the rest of the nation (<1%), suggesting a need to identify clinical points for intervention. METHODS The first 205 cases from this region were reviewed and fatal RMSF cases were compared to nonfatal cases to determine clinical risk factors for fatal outcome. RESULTS Doxycycline was initiated significantly later in fatal cases (median, day 7) than nonfatal cases (median, day 3), although both groups of case patients presented for care early (median, day 2). Multiple factors increased the risk of doxycycline delay and fatal outcome, such as early symptoms of nausea and diarrhea, history of alcoholism or chronic lung disease, and abnormal laboratory results such as elevated liver aminotransferases. Rash, history of tick bite, thrombocytopenia, and hyponatremia were often absent at initial presentation. CONCLUSIONS Earlier treatment with doxycycline can decrease morbidity and mortality from RMSF in this region. Recognition of risk factors associated with doxycycline delay and fatal outcome, such as early gastrointestinal symptoms and a history of alcoholism or chronic lung disease, may be useful in guiding early treatment decisions. Healthcare providers should have a low threshold for initiating doxycycline whenever treating febrile or potentially septic patients from tribal lands in Arizona, even if an alternative diagnosis seems more likely and classic findings of RMSF are absent.


Proteomics Clinical Applications | 2008

Analysis of the human immune response to vaccinia by use of a novel protein microarray suggests that antibodies recognize less than 10% of the total viral proteome

Kara Schmid; Sarah L. Keasey; Phillip R. Pittman; Ginny L. Emerson; James Meegan; Alexander P. Tikhonov; Gengxin Chen; Barry Schweitzer; Robert G. Ulrich

Control of smallpox by mass vaccination was one of the most effective public health measures ever employed for eradicating a devastating infectious disease. However, new methods are needed for monitoring smallpox immunity within current vulnerable populations, and for the development of replacement vaccines for use by immunocompromized or low‐responding individuals. As a measure for achieving this goal, we developed a protein microarray of the vaccinia virus proteome by using high‐throughput baculovirus expression and purification of individual elements. The array was validated with therapeutic‐grade, human hyperimmune sera, and these data were compared to results obtained from individuals vaccinated against smallpox using Dryvax. A high level of reproducibility with a very low background were apparent in repetitive assays that confirmed previously reported antigens and identified new proteins that may be important for neutralizing viral infection. Our results suggest that proteins recognized by antibodies from all vaccinees constituted <10% of the total vaccinia proteome.


Emerging Infectious Diseases | 2013

Phylogenetic and ecologic perspectives of a monkeypox outbreak, southern Sudan, 2005.

Yoshinori Nakazawa; Ginny L. Emerson; Darin S. Carroll; Hui Zhao; Yu Li; Mary G. Reynolds; Kevin L. Karem; Victoria A. Olson; R. Ryan Lash; Whitni Davidson; Scott K. Smith; Rebecca S. Levine; Russell L. Regnery; Scott Sammons; Michael Frace; Elmangory M. Mutasim; Mubarak E.M. Karsani; Mohammed O. Muntasir; Alimagboul A. Babiker; Langova Opoka; Vipul Chowdhary; Inger K. Damon

Identification of human monkeypox cases during 2005 in southern Sudan (now South Sudan) raised several questions about the natural history of monkeypox virus (MPXV) in Africa. The outbreak area, characterized by seasonally dry riverine grasslands, is not identified as environmentally suitable for MPXV transmission. We examined possible origins of this outbreak by performing phylogenetic analysis of genome sequences of MPXV isolates from the outbreak in Sudan and from differing localities. We also compared the environmental suitability of study localities for monkeypox transmission. Phylogenetically, the viruses isolated from Sudan outbreak specimens belong to a clade identified in the Congo Basin. This finding, added to the political instability of the area during the time of the outbreak, supports the hypothesis of importation by infected animals or humans entering Sudan from the Congo Basin, and person-to-person transmission of virus, rather than transmission of indigenous virus from infected animals to humans.


Emerging Infectious Diseases | 2017

Detection and Molecular Characterization of Zoonotic Poxviruses Circulating in the Amazon Region of Colombia, 2014

José Aldemar Usme-Ciro; Andrea Paredes; Diana Walteros; Erica Natalia Tolosa-Pérez; Katherine Laiton-Donato; Maria del Carmen Pinzón; Brett W. Petersen; Nadia F. Gallardo-Romero; Yu Li; Kimberly Wilkins; Whitni Davidson; Jinxin Gao; Nishi Patel; Yoshinori Nakazawa; Mary G. Reynolds; Panayampalli Subbian Satheshkumar; Ginny L. Emerson; Andrés Páez-Martínez

During 2014, cutaneous lesions were reported in dairy cattle and farmworkers in the Amazon Region of western Colombia. Samples from 6 patients were analyzed by serologic and PCR testing, and results demonstrated the presence of vaccinia virus and pseudocowpox virus. These findings highlight the need for increased poxvirus surveillance in Colombia.


Antiviral Research | 2017

The history of rabies in the Western Hemisphere

Andres Velasco-Villa; Matthew R. Mauldin; Mang Shi; Luis E. Escobar; Nadia F. Gallardo-Romero; Inger K. Damon; Victoria A. Olson; Daniel G. Streicker; Ginny L. Emerson

Before the introduction of control programs in the 20th century, rabies in domestic dogs occurred throughout the Western Hemisphere. However, historical records and phylogenetic analysis of multiple virus isolates indicate that, before the arrival of the first European colonizers, rabies virus was likely present only in bats and skunks. Canine rabies was either rare or absent among domestic dogs of Native Americans, and first arrived when many new dog breeds were imported during the period of European colonization. The introduction of the cosmopolitan dog rabies lyssavirus variant and the marked expansion of the dog population provided ideal conditions for the flourishing of enzootic canine rabies. The shift of dog-maintained viruses into gray foxes, coyotes, skunks and other wild mesocarnivores throughout the Americas and to mongooses in the Caribbean has augmented the risk of human rabies exposures and has complicated control efforts. At the same time, the continued presence of bat rabies poses novel challenges in the absolute elimination of canine and human rabies. This article compiles existing historical and phylogenetic evidence of the origins and subsequent dynamics of rabies in the Western Hemisphere, from the era preceding the arrival of the first European colonizers through the present day. A companion article reviews the current status of canine rabies control throughout the Western Hemisphere and steps that will be required to achieve and maintain its complete elimination (Velasco-Villa et al., in press).


Clinical Infectious Diseases | 2015

Rocky Mountain Spotted Fever Characterization and Comparison to Similar Illnesses in a Highly Endemic Area—Arizona, 2002–2011

Marc S. Traeger; Joanna J. Regan; Dwight Humpherys; Dianna L. Mahoney; Michelle Martinez; Ginny L. Emerson; Danielle M. Tack; Aimee Geissler; Seema Yasmin; Regina Lawson; Charlene Hamilton; Velda Williams; Craig Levy; Kenneth Komatsu; Jennifer H. McQuiston; David A. Yost

BACKGROUND Rocky Mountain spotted fever (RMSF) has emerged as a significant cause of morbidity and mortality since 2002 on tribal lands in Arizona. The explosive nature of this outbreak and the recognition of an unexpected tick vector, Rhipicephalus sanguineus, prompted an investigation to characterize RMSF in this unique setting and compare RMSF cases to similar illnesses. METHODS We compared medical records of 205 patients with RMSF and 175 with non-RMSF illnesses that prompted RMSF testing during 2002-2011 from 2 Indian reservations in Arizona. RESULTS RMSF cases in Arizona occurred year-round and peaked later (July-September) than RMSF cases reported from other US regions. Cases were younger (median age, 11 years) and reported fever and rash less frequently, compared to cases from other US regions. Fever was present in 81% of cases but not significantly different from that in patients with non-RMSF illnesses. Classic laboratory abnormalities such as low sodium and platelet counts had small and subtle differences between cases and patients with non-RMSF illnesses. Imaging studies reflected the variability and complexity of the illness but proved unhelpful in clarifying the early diagnosis. CONCLUSIONS RMSF epidemiology in this region appears different than RMSF elsewhere in the United States. No specific pattern of signs, symptoms, or laboratory findings occurred with enough frequency to consistently differentiate RMSF from other illnesses. Due to the nonspecific and variable nature of RMSF presentations, clinicians in this region should aggressively treat febrile illnesses and sepsis with doxycycline for suspected RMSF.


American Journal of Tropical Medicine and Hygiene | 2013

Detection of Human Monkeypox in the Republic of the Congo Following Intensive Community Education

Mary G. Reynolds; Ginny L. Emerson; Elisabeth Pukuta; Stomy Karhemere; Jean Jacques Muyembe; Alain Bikindou; Andrea M. McCollum; Cynthia Moses; Kimberly Wilkins; Hui Zhao; Inger K. Damon; Kevin L. Karem; Yu Li; Darin S. Carroll; Jean V. Mombouli

Monkeypox is an acute viral infection with a clinical course resembling smallpox. It is endemic in northern and central Democratic Republic of the Congo (DRC), but it is reported only sporadically in neighboring Republic of the Congo (ROC). In October 2009, interethnic violence in northwestern DRC precipitated the movement of refugees across the Ubangi River into ROC. The influx of refugees into ROC heightened concerns about monkeypox in the area, because of the possibility that the virus could be imported, or that incidence could increase caused by food insecurity and over reliance on bush meat. As part of a broad-based campaign to improve health standards in refugee settlement areas, the United Nations International Childrens Emergency Fund (UNICEF) sponsored a program of intensive community education that included modules on monkeypox recognition and prevention. In the 6 months immediately following the outreach, 10 suspected cases of monkeypox were reported to health authorities. Laboratory testing confirmed monkeypox virus infection in two individuals, one of whom was part of a cluster of four suspected cases identified retrospectively. Anecdotes collected at the time of case reporting suggest that the outreach campaign contributed to detection of suspected cases of monkeypox.

Collaboration


Dive into the Ginny L. Emerson's collaboration.

Top Co-Authors

Avatar

Darin S. Carroll

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Yu Li

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Inger K. Damon

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Nadia F. Gallardo-Romero

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Mary G. Reynolds

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Kimberly Wilkins

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Yoshinori Nakazawa

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Whitni Davidson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Matthew R. Mauldin

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge